Being Principal Investigators on Pharma-initiated Clinical Trials: Have we Sold Ourselves Too Cheap?

Journal Title: UNKNOWN - Year 2017, Vol 7, Issue 1

Abstract

The other day in clinic I was going through one of those good-clinical-practice (GCP) modules, as requested by one of the pharma companies in order for me to participate as an investigator in one of their clinical trial. As I repetitively wasn't able to correctly answer the minimum 80% of the questions needed for me to pass the final test of the module, my morning hours just flew by, and with my increasing level of anxiety, it suddenly dawned on me-we, physician-investigators participating in pharma-initiated clinical trials, have sold ourselves too cheap.

Authors and Affiliations

Leibowitz-Amit R

Keywords

Related Articles

Cutaneous Necrosis after Peripheral Venous Perfusion of Adrenaline

A 30 year old female patient was hospitalized for septic shock owing to peritonitis due to perforated viscus. The patient’s hemodynamic status was labile and a peripheral venous access line was established for the perfus...

Editor’s Note: Journal of Clinical Trials

In clinical research, several studies use to perform on human subjects to evaluate the dependence of the disease occurrence with one or more parameters. Such studies are called 'Clinical trials', which are having great i...

Nivolumab Maintenance as Monotherapy after Carboplatin Plus Nab- Paclitaxel for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Study Protocol for Feasibility

The aim of this study is to determine the feasibility of nivolumab as maintenance therapy after first-line chemotherapy with carboplatin plus nab-paclitaxel in non-small-cell lung cancer. Since we cannot change the dose...

Myocardial Ischemia and Infarction Related to the Highly Sensitive Cardiac Troponin after Noncardiac Surgery: A Review

Although Acute Myocardial Infarct (AMI) from its classic symptomatology added or not to electrocardiographic changes is a significant cause of perioperative associated mortality, when it is only plotted from the enzymati...

Assessment of Human Natriuretic Peptides (B), Human N-Terminal Pro-BNP and Nor-epinephrine as Neurohumoral Markers in Sleep Disordered Breathing among Heart Failure Patients in Upper Egypt

Objective: The purposes of this study are to: (1) Measure neurohumoral activation in heart failure patients with and without Sleep Disordered Breathing; (2) Assessment of neurohumoral markers with the severity of sleep a...

Download PDF file
  • EP ID EP382344
  • DOI 10.4172/2167-0870.1000295
  • Views 28
  • Downloads 0

How To Cite

Leibowitz-Amit R (2017). Being Principal Investigators on Pharma-initiated Clinical Trials: Have we Sold Ourselves Too Cheap?. UNKNOWN, 7(1), 1-2. https://europub.co.uk/articles/-A-382344